Speech Therapy in the Management of Chronic Cough

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03457610
• Date of registration: 01/03/2018
• Prospective Registration: No
• Primary sponsor: Medical University of Warsaw
• Public title: Speech Therapy in the Management of Chronic Cough
• Scientific title: Speech Therapy in the Management of Difficult-to-treat Chronic Cough
• Date of first enrolment: January 1, 2016
• Target sample size: 30
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03457610
• Study type: Interventional
• Study design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Poland

Key inclusion & exclusion criteria

Inclusion Criteria:

1. age between 18 and 80 years,

2. chronic cough lasting more than six months

3. earlier thorough diagnosing of cough reason

4. unsuccessful cough management despite at least 3 months of earlier treatment

5. no symptoms of any airway infection during last 4 weeks.

Exclusion Criteria:

1. lack of opportunity to participate in speech therapy sessions

2. cough lasting less than 6 months

3. active cigarette smoking

4. taking ACE inhibitors

5. symptoms of airway infection (other than cough).



Age minimum: 18 Years
Age maximum: 80 Years
Gender: All

Health Condition(s) or Problem(s) studied

Speech Therapy

Cough

Intervention(s)

Behavioral: Speech and language intervention

Primary Outcome(s)

Cough severity [Time Frame: 3 months]

Secondary Outcome(s)

Cough related quality of life [Time Frame: 3 months]

Sensitivity of cough reflex [Time Frame: 3 months]

Secondary ID(s)

Pulm2017

Source(s) of Monetary Support

Please refer to primary and secondary sponsors